Hasil Pencarian - F.A. Holmes
- Menampilkan 1 - 2 hasil dari 2
-
1
-
2
Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial oleh M. Martin, F.A. Holmes, B. Moy, J. Mansi, M. Gnant, M. Buyse, C. Barrios, R. Bryce, A. Wong, A. Chan
Diterbitkan 2021-04-01Dapatkan teks lengkap
Artikel